Terasin Dosage & Drug Information

Concise Prescribing Info

Contents

Terazosin HCl

Indications/Uses

Symptomatic treatment of benign prostatic hyperplasia (BPH). HTN.

Dosage/Direction for Use

Initially 1 mg at bedtime. BPH 5-10 mg once daily. HTN 1-5 mg once daily, up to 20 mg daily.

Administration

May be taken with or without food.

Contraindications

Pregnancy.

Special Precautions

Rule out presence of prostatic cancer prior to treatment. May affect ability to drive or operate machinery. Lactation.

Adverse Reactions

Asthenia, postural hypotension, dizziness, somnolence, nasal congestion/rhinitis, impotence, blurred vision, nausea, peripheral edema, palpitations.

View ADR Monitoring Form

MIMS Class

ATC Classification

G04CA03 - terazosin ; Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.

Regulatory Classification

Presentation/Packing

Form

Terasin tab 2 mg

Packing/Price

10 × 10's

Form

Terasin tab 5 mg

Packing/Price

10 × 10's

Terasin